Some with severe sickle cell disease in England will now be able to access landmark CRISPR gene editing therapy, according to ...
A cutting-edge gene therapy has been approved for NHS use for some patients with severe sickle cell disease ... to be licensed using gene-editing tool Crispr, which earned its inventors the ...
The CRISPR-based gene therapy Casgevy (exagamglogene autotemcel) has been made available to patients with sickle cell disease in England, following positive guidance issued by the National ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results